Skip to main content
. 2020 Jan 27;21(3):811. doi: 10.3390/ijms21030811

Table 1.

Recent studies on lysosome dysfunction in cardiovascular disease.

Lysosome Function Lysosomal Component/Pathway Disease/Models References
Insufficient V-ATPase/lysosome acidification Doxorubicin-induced cardiotoxicity [28]
TFEB/biogenesis cardiac proteinopathy/desmin-related cardiomyopathy [17]
LAMP-2B/autophagy Danon disease [9]
TFEB/biogenesis Myocardial I/R injury [19]
Excessive Cathepsin B Coronary heart disease (CLARICOR trial) [24]
Cathepsin B Mucopolysaccharidosis type I [25]